Sophia Genetics raises $30M

By September 21, 2017Portfolio
Sophia Genetics CEO

Sophia Genetics, a healthcare startup backed by Autonomy billionaire Mike Lynch, has raised $30 million (£23 million) for its medical software platform. The funding round brings total investment in the startup up to around $60 million (£45 million).

The funding round was led by London-headquartered venture capital firm Balderton Capital, together with 360 Capital Partners, while Invoke Capital (Mike Lynch’s startup investment company), and Belgian pharmaceutical entrepreneur Mark Coucke also participated.

More information